Site Map

Study puts MRI contrast agents to the test

Sectra posts strong Q1

MRI market to top $4 billion by 2010

PowerFile unveils A3T

Bioscan licenses IDSI molecular imaging technology

From tears to TKA: The ins and outs of knee MRI

Better enhancement, fewer artifacts seen with certain -- but not all -- MR contrast agents

Page 1 of 1